Shefali Agarwal Net Worth & Insider Trades
Shefali Agarwal Epizyme, Inc
What is Shefali Agarwal's Net Worth?
The current estimated net worth of Epizyme, Inc's Shefali Agarwal is estimated to be about $343.61K . Shefali Agarwal owns about 156,385 units of Epizyme, Inc common stock. In the last 4 years at Epizyme, Inc, Shefali Agarwal has sold an estimated value of $774.4K worth.
What is Shefali Agarwal's Past Insider Trading?
Shefali Agarwal's largest sale order was 4,473 units , worth over $99.17K on January 27, 2020. In total, Shefali Agarwal has made about 21 transactions over 4 years of their time at Epizyme, Inc. Shefali Agarwal usually trades in February, with the busiest year in 2022. The most recent transaction was a sale order of 1,058 units , worth over $1.59K on February 9, 2022.
Shefali Agarwal
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Shefali Agarwal's Salary in 2020?
As an executive member of Epizyme, Inc, Shefali Agarwal has a total base salary of $478,000 . Shefali Agarwal received compensation valued at about $1,785,747 in 2020. The vast majority of their compensation came in the form of restricted stock awards of $274,990 , option awards of $825,799 , other earnings, plans or compensations of $199,804 , and other compensation of $7,154 .
What is Shefali Agarwal's' Mailing Address?
- Mailing address is C/o Epizyme, Inc., 400 Technology Square Cambridge MA 02139 MA
Epizyme, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Restricted Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Robert B. Bazemore Jr. | 2020 | $650,000 | - | $3,237,620 | $4,103,853 | $370,500 | $96,369 | $8,458,342 |
| Robert B. Bazemore Jr. | 2019 | $592,937 | - | $1,105,393 | $2,060,531 | $409,127 | $5,630 | $4,173,618 |
| Robert B. Bazemore Jr. | 2018 | $575,667 | - | - | $2,748,939 | $320,575 | $5,690 | $3,650,871 |
| Paolo Tombesi | 2020 | $460,000 | - | $250,006 | $750,730 | $174,800 | $48,198 | $1,683,734 |
| Paolo Tombesi | 2019 | $168,901 | - | $612,848 | $1,173,669 | $76,076 | $146,971 | $2,178,465 |
| Matthew E. Ros | 2020 | $447,982 | - | $250,006 | $750,730 | $174,800 | $11,271 | $1,634,789 |
| Matthew E. Ros | 2019 | $432,600 | - | $538,793 | $899,137 | $199,861 | $11,598 | $2,081,989 |
| Matthew E. Ros | 2018 | $420,000 | - | - | $1,099,576 | $187,100 | $12,214 | $1,718,890 |
| Dr. Shefali Agarwal | 2020 | $478,000 | - | $274,990 | $825,799 | $199,804 | $7,154 | $1,785,747 |
| Dr. Shefali Agarwal | 2019 | $463,500 | - | $894,607 | $1,255,325 | $265,122 | $8,652 | $2,887,206 |
| Dr. Shefali Agarwal | 2018 | $199,615 | $125,000 | - | $1,472,846 | $200,500 | $1,648 | $1,999,609 |
| Jeffery L. Kutok, M.D., Ph.D. | 2020 | $337,500 | $85,000 | $374,996 | $1,124,996 | $134,663 | $6,813 | $2,063,968 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1571498/000119312521138283/d839557ddef14a.htm
What are Epizyme, Inc's Past Insider Trades?
Epizyme, Inc's most recent insider trade came on April 13, 2022 by Jeffery Kutok who sold 2,741 units worth $2.47K . In the last 9 years, insiders at Epizyme, Inc have sold an estimated value of $156.28M and bought an estimated value of $381.12M worth of shares. Insider trading is most common in June, with the busiest year in 2014. The most active traders at the company are David Mott, Director, Robert Copeland, President Research and CSO, and Andrew Singer, EVP & CFO .
Epizyme, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||